Biolase Inc Reports Results For The Quarter Ended In September: Earnings Summary

November 26

10/11/2022 22:02

* BIOLASE Inc  BIOL.OQ  reported a quarterly adjusted loss
of
$1.10​​ per share for the quarter ended in September. The mean
expectation of four analysts for the quarter was for a loss
of 84 cents per share.
    * Revenue rose 26% to $12.01 million from a year ago;
analysts
expected $10.65 million. 
    * BIOLASE Inc's reported EPS for the quarter was a loss of
$1.10​.
    * The mean earnings estimate of analysts had fallen by
about 41.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * BIOLASE Inc shares had fallen by 42.0% this quarter and
lost 85.5% so far this year.
    * The company reported a quarterly loss of $8.39 million.
    * Wall Street's median 12-month price target for BIOLASE Inc
is
$18.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.84          -1.10          Missed
 Jun. 30 2022      -0.62          -0.91          Missed
 Mar. 31 2022      -0.68          -0.81          Missed
 Dec. 31 2021      -0.62          -0.75          Missed